SCHEMBL4667093

SCHEMBL4667093

CCc1cc(N)n(-c2ccncc2)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 7/20 0.43
▸ SMN1; SMN2 Q16637 7/20 0.43
▸ NPC1 O15118 6/20 0.43
▸ NFKB1 P19838 2/20 0.43
▸ NFKB2 Q00653 2/20 0.43
▸ RELA Q04206 2/20 0.43
▸ CYP1A2 P05177 2/20 0.42
▸ CYP2C19 P33261 2/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ CA12 O43570 1/20 0.42
▸ CA1 P00915 1/20 0.42
▸ CA2 P00918 1/20 0.42
▸ CA9 Q16790 1/20 0.42
▸ POLB P06746 2/20 0.40
▸ MEN1 O00255 4/20 0.39
▸ KMT2A Q03164 4/20 0.39
▸ MAPT P10636 3/20 0.39
▸ TP53 P04637 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1013253 0.84 CYP1A2 (0.61) RAB9ASMN1; SMN2NPC1NFKB1NFKB2
SCHEMBL27702044 0.84 CNR2 (0.46) RAB9ASMN1; SMN2NPC1NFKB1NFKB2
SCHEMBL2474225 0.83 RAB9A (0.58) RAB9ASMN1; SMN2NPC1NFKB1NFKB2
SCHEMBL18925837 0.81 NPC1 (0.54) RAB9ASMN1; SMN2NPC1NFKB1NFKB2
SCHEMBL11687153 0.81 POLB (0.43) RAB9ASMN1; SMN2NPC1NFKB1NFKB2
SCHEMBL6350912 0.77 CYP1A2 (0.70) RAB9ASMN1; SMN2NPC1NFKB1NFKB2
SCHEMBL4665822 0.76 CA12 (0.46) CYP1A2CYP2C19MAPK1CA12CA1
SCHEMBL1012922 0.72 MAPK13 (0.48) RAB9ASMN1; SMN2NPC1CYP1A2CYP2C19
SCHEMBL2899043 0.72 ALDH1A1 (0.56) RAB9ASMN1; SMN2CYP1A2MAPK1CA12
SCHEMBL2029110 0.72 ALDH1A1 (0.47) RAB9ASMN1; SMN2NPC1CYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1928455-A1 ANILINOPYRAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DIABETES Bayer Healthcare, LLC (US) 2008-06-11 — — EP disclosed
WO-2007027842-A1 ANILINOPYRAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DIABETES BAYER HEALTHCARE LLC (US) 2007-03-08 — — WO disclosed
WO-2007027842-A1 ANILINOPYRAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DIABETES BAYER HEALTHCARE LLC (US) 2007-03-08 — — WO disclosed
Send feedback